ArticleChembiochem : a European journal of chemical biology2026
Benzylamine-Based Organoselenium Compounds as Glutathione Peroxidase Mimics: Antioxidant and Antibacterial Agents.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Benzylamine-based organoselenium compounds were designed and synthesized to explore their antioxidant and antibacterial properties. The synthetic strategy involves nucleophilic substitution of benzyl bromides with in situ generated sodium selenolate, obtained from sodium borohydride reduction of the corresponding diselenides, affording the desired products. The multifunctional antioxidant properties, including radical-trapping and glutathione peroxidase-like antioxidant activities were evaluated using 2,2-diphenyl-1-picrylhydrazyl and thiophenol assay, respectively. These antioxidants exhibited good cell viability at 2 µM and displayed in vitro antibacterial activity against gram-negative Escherichia coli and gram-positive Staphylococcus aureus. These were further supported by in silico study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.